Severity: Warning
Message: fopen(/var/lib/php/sessions/ci_sessionbbn0kk6oi8fa13rqu3tang1iri0db4fq): Failed to open stream: No space left on device
Filename: drivers/Session_files_driver.php
Line Number: 177
Backtrace:
File: /var/www/html/index.php
Line: 316
Function: require_once
Severity: Warning
Message: session_start(): Failed to read session data: user (path: /var/lib/php/sessions)
Filename: Session/Session.php
Line Number: 137
Backtrace:
File: /var/www/html/index.php
Line: 316
Function: require_once
5,337 results match your criteria: "Lentigo"
Clin Exp Dermatol
February 2025
Department of Dermatology, Norfolk and Norwich University Hospital, Norwich, UK.
Cutaneous melanoma in situ (MIS), also known as 'stage 0 melanoma', is a collection of malignant melanocytes in the epidermis and epithelial adnexa, without evidence of microinvasion to the papillary dermis. Distinct histological subtypes include lentigo maligna (LM), superficial spreading (SS) MIS and acral lentiginous (AL) MIS. LM is the most common subtype, usually diagnosed later in life (median age at diagnosis of 66-72 years) and associated with cumulative ultraviolet radiation exposure.
View Article and Find Full Text PDFJ Am Acad Dermatol
October 2024
Department of Dermatology, Massachusetts General Hospital, Boston, MA 02114, USA; Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. Electronic address:
Lentigo Maligna (LM) arises on chronically-sun damaged skin and can have extensive subclinical spread, often in functionally and cosmetically challenging areas. This two-part continuing medical education (CME) series reviews LM. Part I reviews epidemiology, risk factors, clinical presentation, diagnostic tools, biopsy technique, and histopathology of LM.
View Article and Find Full Text PDFJ Am Acad Dermatol
October 2024
Department of Dermatology, Massachusetts General Hospital, Boston, MA 02114, USA; Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. Electronic address:
Lentigo maligna (LM) is an increasingly common subtype of melanoma, presenting as a slow-growing tan-brown macule or patch with irregular borders arising on chronically solar-damaged skin. This two-part continuing medical education (CME) series provides an overview of LM. Part I reviews LM's epidemiology, risk factors, and clinical presentation.
View Article and Find Full Text PDFSkinmed
October 2024
Empire Dermatology (Private Practice), Syracuse, NY.
J Surg Oncol
October 2024
Department of Surgical Oncology, Corewell Health, Grand Rapids, Michigan, USA.
Melanoma affects over one million people in the United States. This review explores genetic mutations and markers of all seven subtypes. Current treatment options and prognosis of each subtype are also discussed.
View Article and Find Full Text PDFJ Clin Aesthet Dermatol
January 2024
Ms. Hennessey is the Owner of Blush Aesthetics in Perrysburg and Toledo, Ohio, and Assistant Professor, Nursing, Gonzaga University in Spokane, Washington.
Exp Dermatol
October 2024
Oncologic Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Acta Derm Venereol
October 2024
Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sweden; Region Västra Götaland, Sahlgrenska University Hospital, Department of Dermatology and Venereology, Gothenburg, Sweden.
Dermatol Surg
February 2025
Department of Dermatology, Mayo Clinic, Rochester, Minnesota.
Br J Dermatol
January 2025
Department of Dermatology, University of Nebraska Medical Center, Omaha, NE, USA.
JAAD Case Rep
October 2024
Mountain West Dermatology, Grand Junction, Colorado.
J Psychosom Obstet Gynaecol
December 2024
Department of Nursing, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, China.
Actas Dermosifiliogr
March 2025
Servicio de Dermatología, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, España; Servicio de Dermatología, Hospital de Figueres, Fundació Salut Empordà, Figures, Girona, España. Electronic address:
Skin Res Technol
September 2024
Department of Dermatology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.
J Dermatolog Treat
December 2024
Department of Dermatology, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul, Korea.
Br J Dermatol
December 2024
Cellular Pathology Services, Watford, UK.
J Cosmet Dermatol
December 2024
Foshan Conney Allan Biotechnology Co. Ltd, Foshan, China.
Diagn Pathol
September 2024
Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Aust J Gen Pract
September 2024
FACD, Director of Dermatology, Mater Hospital, Brisbane, Qld; Dermatologist, South East Dermatology, Annerley, Qld; Associate Professor, University of Queensland, Medical Faculty, Brisbane, Qld.
Adv Anat Pathol
January 2025
Department of Pathology, Massachusetts General Hospital, Boston, MA.
STK11 adnexal tumor is a novel malignant neoplasm of uncertain histogenesis frequently arising in a para-adnexal location and associated with Peutz-Jeghers syndrome in ∼50% of patients. Its broad morphologic spectrum and nonspecific immunohistochemical profile has resulted in misclassification in the past as a variety of other neoplasms including those of wolffian, sex cord-stromal, mesothelial, and epithelial derivation. This review focuses on the spectrum of adnexal neoplasms that may develop in Peutz-Jeghers syndrome, with particular emphasis on STK11 adnexal tumor and its differential diagnosis.
View Article and Find Full Text PDFJ Clin Med
August 2024
Department of Dermatovenereology, Sestre Milosrdnice University Hospital Center, HR-10000 Zagreb, Croatia.
J Clin Med
August 2024
Department of Ophthalmology, University of Catania, 95123 Catania, Italy.
Clin Cancer Res
October 2024
Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas.